SCHEMBL30708692

SCHEMBL30708692

c1cnc2cc(-c3cc4ncccn4n3)nn2c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.61
APOBEC3G Q9HC16 1/20 0.61
DYRK1A Q13627 2/20 0.44
PDE10A Q9Y233 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CLK4 Q9HAZ1 3/20 0.37
JAK2 O60674 3/20 0.37
MAP4K4 O95819 2/20 0.37
PRKACA P17612 2/20 0.37
CDK8 P49336 2/20 0.37
LRRK2 Q5S007 2/20 0.37
RET P07949 2/20 0.37
KDR P35968 2/20 0.37
GSK3A P49840 2/20 0.37
RPS6KA3 P51812 2/20 0.37
LIMK1 P53667 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30118007 0.90 APOBEC3A (0.56) APOBEC3AAPOBEC3GDYRK1APDE10ANPC1
SCHEMBL30798766 0.89 APOBEC3A (0.51) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
SCHEMBL1665644 0.88 APOBEC3A (0.54) APOBEC3AAPOBEC3GDYRK1APDE10ANPC1
SCHEMBL21076234 0.87 DYRK1A (0.60) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
SCHEMBL30118009 0.86 APOBEC3A (0.49) APOBEC3AAPOBEC3GDYRK1APDE10ANPC1
SCHEMBL1015835 0.85 DYRK1A (0.62) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
Hydrochloric Acid SCHEMBL25276515 0.83 DYRK1A (0.60) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
SCHEMBL4154898 0.82 MAPT (0.49) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
SCHEMBL5060955 0.82 APOBEC3A (0.49) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A
SCHEMBL5946565 0.82 APOBEC3A (0.49) APOBEC3AAPOBEC3GDYRK1ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120442-A Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders 薛定谔公司 2023-11-24 CN disclosed